My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.

    Lapensee EW, Tuttle TR, Fox SR, Ben-Jonathan N.

    Environ Health Perspect. 2009 Feb;117(2):175-80. Epub 2008 Oct 8.PMID: 19270784 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.

    Vivacqua A, Recchia AG, Fasanella G, Gabriele S, Carpino A, Rago V, Di Gioia ML, Leggio A, Bonofiglio D, Liguori A, Maggiolini M.

    Endocrine. 2003 Dec;22(3):275-84.PMID: 14709801 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.

    Diel P, Olff S, Schmidt S, Michna H.

    J Steroid Biochem Mol Biol. 2002 Jan;80(1):61-70.PMID: 11867264 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells.

    Singleton DW, Feng Y, Chen Y, Busch SJ, Lee AV, Puga A, Khan SA.

    Mol Cell Endocrinol. 2004 Jun 30;221(1-2):47-55.PMID: 15223131 [PubMed - indexed for MEDLINE]Related articles

    5.

    Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta.

    Hiroi H, Tsutsumi O, Momoeda M, Takai Y, Osuga Y, Taketani Y.

    Endocr J. 1999 Dec;46(6):773-8.PMID: 10724352 [PubMed - indexed for MEDLINE]Related articles

    6.

    Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes.

    Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N.

    Environ Health Perspect. 2008 Dec;116(12):1642-7. Epub 2008 Aug 14.PMID: 19079714 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.

    Recchia AG, Vivacqua A, Gabriele S, Carpino A, Fasanella G, Rago V, Bonofiglio D, Maggiolini M.

    Food Addit Contam. 2004 Feb;21(2):134-44.PMID: 14754635 [PubMed - indexed for MEDLINE]Related articles

    8.

    Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor.

    Bouskine A, Nebout M, Brücker-Davis F, Benahmed M, Fenichel P.

    Environ Health Perspect. 2009 Jul;117(7):1053-8. Epub 2009 Feb 11.PMID: 19654912 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.

    Long X, Fan M, Bigsby RM, Nephew KP.

    Mol Cancer Ther. 2008 Jul;7(7):2096-108.PMID: 18645020 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.

    Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, Motoki T, Yamatsuji T, Shirakawa Y, Takaoka M, Haisa M, Tanaka N, Kurebayashi J, Jordan VC, Naomoto Y.

    Int J Oncol. 2009 Feb;34(2):313-9.PMID: 19148464 [PubMed - indexed for MEDLINE]Related articles

    11.

    In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta.

    Matthews JB, Twomey K, Zacharewski TR.

    Chem Res Toxicol. 2001 Feb;14(2):149-57.PMID: 11258963 [PubMed - indexed for MEDLINE]Related articles

    12.

    Neonatal exposure to bisphenol A modifies the abundance of estrogen receptor alpha transcripts with alternative 5'-untranslated regions in the female rat preoptic area.

    Monje L, Varayoud J, Luque EH, Ramos JG.

    J Endocrinol. 2007 Jul;194(1):201-12.PMID: 17592034 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.

    Kuske B, Naughton C, Moore K, Macleod KG, Miller WR, Clarke R, Langdon SP, Cameron DA.

    Endocr Relat Cancer. 2006 Dec;13(4):1121-33.PMID: 17158758 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals.

    Bolli A, Galluzzo P, Ascenzi P, Del Pozzo G, Manco I, Vietri MT, Mita L, Altucci L, Mita DG, Marino M.

    IUBMB Life. 2008 Dec;60(12):843-52.PMID: 18767177 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.

    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.

    Int J Oncol. 2005 Apr;26(4):1025-31.PMID: 15753998 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.

    LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassi el M, Afton SE, Ben-Jonathan N.

    Carcinogenesis. 2009 Aug;30(8):1298-304. Epub 2009 May 14.PMID: 19443905 [PubMed - indexed for MEDLINE]Related articles

    17.

    Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.

    Sui M, Huang Y, Park BH, Davidson NE, Fan W.

    Cancer Res. 2007 Jun 1;67(11):5337-44.PMID: 17545614 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

    Hosey AM, Gorski JJ, Murray MM, Quinn JE, Chung WY, Stewart GE, James CR, Farragher SM, Mulligan JM, Scott AN, Dervan PA, Johnston PG, Couch FJ, Daly PA, Kay E, McCann A, Mullan PB, Harkin DP.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1683-94. Epub 2007 Nov 13.PMID: 18000219 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.

    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.

    Cancer Res. 2002 Sep 1;62(17):4977-84.PMID: 12208749 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

    Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

    Mol Cancer Res. 2008 Aug;6(8):1347-55.PMID: 18708366 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity